Molecular diagnostics company, Mobidiag (Espoo, Finland), has announced that it has initiated the development of a diagnostic assay for the simultaneous detection of novel coronavirus (2019-nCoV) and influenza viruses.
Browsing: diagnostic assay
Scientists based at the German Center for Infection Research (DZIF) at Charité, Universitätsmedizin Berlin (Germany) have developed a new assay to detect the 2019 novel Chinese coronavirus.
Researchers have analyzed flotillin levels in samples from individuals with and without Alzheimer’s disease (AD) and determined that serum flotillin levels are negatively associated with brain amyloid deposition. Flotillin could serve as a biomarker to estimate brain amyloid deposition, potentially aiding the early diagnosis of AD.
Thermo Fisher Scientific (MA, USA) have announced the launch of a new complementary diagnostic immunoassay, the Thermo Scientific QMS Plazomicin Immunoassay, for measuring the concentration of a novel therapeutic antibiotic, plazomicin, used to treat complicated urinary tract infections.
New technology could render point-of-care diagnoses less expensive and much easier to use in remote environments with limited resources.
Researchers have identified a panel of biomarkers in serum samples that could accurately detect the early stages of pancreatic cancer.
An assay developed by PerkinElmer has been utilized for the Fetal Medicine Foundation’s ASPRE study to successfully identify women at risk of preeclampsia.
Researchers have discovered a new biomarker that could detect the risk of cardiovascular disease in asymptomatic patients with lupus.
Beckman Coulter showcase the Beckman Coulter Diagnostic Difference and a range of new products designed to provide comprehensive solutions for laboratory excellence.
PerkinElmer have developed a new immunoassay that can reliably screen for Duchenne muscular dystrophy in new born infants.